An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating
subjects suffering moderate pain form a migraine attack, with or without aura. The study is
also intended to show the effectiveness of PRO-513 for associated symptoms of nausea,
photophobia, and phonophobia due to a migraine attack.